295 related articles for article (PubMed ID: 1647298)
21. Concanavalin A stimulates the Rolipram-sensitive isoforms of cyclic nucleotide phosphodiesterase in rat thymic lymphocytes.
Valette L; Prigent AF; Némoz G; Anker G; Macovschi O; Lagarde M
Biochem Biophys Res Commun; 1990 Jun; 169(3):864-72. PubMed ID: 2163636
[TBL] [Abstract][Full Text] [Related]
22. Role of cyclic nucleotide phosphodiesterase isozymes in intact canine trachealis.
Torphy TJ; Zhou HL; Burman M; Huang LB
Mol Pharmacol; 1991 Mar; 39(3):376-84. PubMed ID: 1848659
[TBL] [Abstract][Full Text] [Related]
23. Characterization of phosphodiesterase 4 in guinea-pig macrophages: multiple activities, association states and sensitivity to selective inhibitors.
Kelly JJ; Barnes PJ; Giembycz MA
Br J Pharmacol; 1998 May; 124(1):129-40. PubMed ID: 9630352
[TBL] [Abstract][Full Text] [Related]
24. Inhibitors of cyclic nucleotide phosphodiesterase isozymes block renal tubular cell proliferation induced by folic acid.
Matousovic K; Tsuboi Y; Walker H; Grande JP; Dousa TP
J Lab Clin Med; 1997 Nov; 130(5):487-95. PubMed ID: 9390636
[TBL] [Abstract][Full Text] [Related]
25. ADH resistance of LLC-pk1 cells caused by overexpression of cAMP-phosphodiesterase type-IV.
Yamaki M; McIntyre S; Murphy JM; Swinnen JV; Conti M; Dousa TP
Kidney Int; 1993 Jun; 43(6):1286-97. PubMed ID: 8391097
[TBL] [Abstract][Full Text] [Related]
26. Characterization of cyclic nucleotide phosphodiesterases from cultured bovine aortic endothelial cells.
Lugnier C; Schini VB
Biochem Pharmacol; 1990 Jan; 39(1):75-84. PubMed ID: 2153383
[TBL] [Abstract][Full Text] [Related]
27. Selective effects of phosphodiesterase inhibitors on different phosphodiesterases, adenosine 3',5'-monophosphate metabolism, and lipolysis in 3T3-L1 adipocytes.
Elks ML; Manganiello VC
Endocrinology; 1984 Oct; 115(4):1262-8. PubMed ID: 6207009
[TBL] [Abstract][Full Text] [Related]
28. Formation of reactive oxygen metabolites in glomeruli is suppressed by inhibition of cAMP phosphodiesterase isozyme type IV.
Chini CC; Chini EN; Williams JM; Matousovic K; Dousa TP
Kidney Int; 1994 Jul; 46(1):28-36. PubMed ID: 7933846
[TBL] [Abstract][Full Text] [Related]
29. Inhibition of pig aortic smooth muscle cell DNA synthesis by selective type III and type IV cyclic AMP phosphodiesterase inhibitors.
Souness JE; Hassall GA; Parrott DP
Biochem Pharmacol; 1992 Sep; 44(5):857-66. PubMed ID: 1326964
[TBL] [Abstract][Full Text] [Related]
30. Characterization of cyclic AMP phosphodiesterase isozymes in rat parotid gland.
Imai A; Nashida T; Shimomura H
Arch Oral Biol; 1995 Feb; 40(2):165-8. PubMed ID: 7794130
[TBL] [Abstract][Full Text] [Related]
31. Isozymes of cyclic-3',5'-nucleotide phosphodiesterases in renal epithelial LLC-PK1 cells.
Rassier ME; McIntyre SJ; Yamaki M; Takeda S; Lin JT; Dousa TP
Kidney Int; 1992 Jan; 41(1):88-99. PubMed ID: 1343559
[TBL] [Abstract][Full Text] [Related]
32. The effect of cyclic AMP and cyclic GMP phosphodiesterase inhibitors on the superoxide burst of guinea-pig peritoneal macrophages.
Turner NC; Wood LJ; Burns FM; Gueremy T; Souness JE
Br J Pharmacol; 1993 Apr; 108(4):876-83. PubMed ID: 8387385
[TBL] [Abstract][Full Text] [Related]
33. [Effect of several hormones on cyclic 3',5'-nucleotide phosphodiesterase in rat kidneys].
Iwase K
Nihon Naibunpi Gakkai Zasshi; 1983 Oct; 59(10):1678-91. PubMed ID: 6319206
[TBL] [Abstract][Full Text] [Related]
34. Pathogenesis of nephrogenic diabetes insipidus due to chronic administration of lithium in rats.
Christensen S; Kusano E; Yusufi AN; Murayama N; Dousa TP
J Clin Invest; 1985 Jun; 75(6):1869-79. PubMed ID: 2989335
[TBL] [Abstract][Full Text] [Related]
35. Purification and characterization of guanosine 3',5'-monophosphate-inhibited low K(m) adenosine 3',5'-monophosphate phosphodiesterase from human placental cytosolic fractions.
LeBon TR; Kasuya J; Paxton RJ; Belfrage P; Hockman S; Manganiello VC; Fujita Yamaguchi Y
Endocrinology; 1992 Jun; 130(6):3265-74. PubMed ID: 1317779
[TBL] [Abstract][Full Text] [Related]
36. Specific effects of n-3 fatty acids and 8-bromo-cGMP on the cyclic nucleotide phosphodiesterase activity in neonatal rat cardiac myocytes.
Picq M; Dubois M; Grynberg A; Lagarde M; Prigent AF
J Mol Cell Cardiol; 1996 Oct; 28(10):2151-61. PubMed ID: 8930810
[TBL] [Abstract][Full Text] [Related]
37. Suppression of mesangial proliferative glomerulonephritis development in rats by inhibitors of cAMP phosphodiesterase isozymes types III and IV.
Tsuboi Y; Shankland SJ; Grande JP; Walker HJ; Johnson RJ; Dousa TP
J Clin Invest; 1996 Jul; 98(2):262-70. PubMed ID: 8755633
[TBL] [Abstract][Full Text] [Related]
38. Role of cyclic AMP- and cyclic GMP-phosphodiesterases in the control of cyclic nucleotide levels and smooth muscle tone in rat isolated aorta. A study with selective inhibitors.
Schoeffter P; Lugnier C; Demesy-Waeldele F; Stoclet JC
Biochem Pharmacol; 1987 Nov; 36(22):3965-72. PubMed ID: 2825708
[TBL] [Abstract][Full Text] [Related]
39. Characterization of a liver low Michaelis-Menten constant 3',5'-cyclic adenosine monophosphate phosphodiesterase activity sensitive to thyroid status.
Benelli C; Geoffroy V; Fouque F; Lopez S; Desbuquois B
Endocrinology; 1991 May; 128(5):2376-86. PubMed ID: 1850351
[TBL] [Abstract][Full Text] [Related]
40. Regulation of adenosine 3',5'-cyclic monophosphate (cAMP) accumulation in UMR-106 osteoblast-like cells: role of cAMP-phosphodiesterase and cAMP efflux.
Ahlström M; Lamberg-Allardt C
Biochem Pharmacol; 1999 Oct; 58(8):1335-40. PubMed ID: 10487537
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]